August 11, 2023 04:28 AM EDTUpdated 06:22 AM

Voyager taps new business chief amid 'significant interest' from partners; Oncopeptides faces another CEO, CFO reset

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Nicole DeFeudis

Editor

Beth Shafer was taught to leave a place better than she found it. As Voyager Therapeutics’ new chief business officer, that’s exactly what she intends …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Voyager taps new business chief amid 'significant interest' from partners; Oncopeptides faces another CEO, CFO reset

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Nicole DeFeudis

Editor

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people

Summit says bispecific misses overall survival in closely-watched lung cancer study

Summit’s disappointing survival readout raises stakes for full data

Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

Arvinas, Pfizer's PROTAC in breast cancer no better than oral SERDs

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Voy­ager taps new busi­ness chief amid 'sig­nif­i­cant in­ter­est' from part­ners; On­copep­tides faces an­oth­er CEO, CFO re­set

Copy Chief

Editor

Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Voyager taps new business chief amid 'significant interest' from partners; Oncopeptides faces another CEO, CFO reset